Dasatinib targets chronic myeloid leukemia-CD34(+) progenitors as effectively as it targets mature cells

Por Hiwase, Devendra K., Saunders, Verity A., Nievergall, Eva, Ross, Douglas D., White, Deborah L., Hughes, Timothy P.
Publicado em 2013

Impaired haematopoietic stem cell differentiation and enhanced skewing towards myeloid progenitors in aged caspase-2-deficient mice

Por Dawar, Swati, Shahrin, Nur Hezrin, Sladojevic, Nikolina, D'Andrea, Richard J, Dorstyn, Loretta, Hiwase, Devendra K, Kumar, Sharad
Publicado no Cell Death Dis (2016)

Loss of caspase-2 augments lymphomagenesis and enhances genomic instability in Atm-deficient mice

Por Puccini, Joseph, Shalini, Sonia, Voss, Anne K., Gatei, Magtouf, Wilson, Claire H., Hiwase, Devendra K., Lavin, Martin F., Dorstyn, Loretta, Kumar, Sharad
Publicado em 2013

TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets

Por Yeung, David T., Osborn, Michael P., White, Deborah L., Branford, Susan, Braley, Jodi, Herschtal, Alan, Kornhauser, Michael, Issa, Samar, Hiwase, Devendra K., Hertzberg, Mark, Schwarer, Anthony P., Filshie, Robin, Arthur, Christopher K., Kwan, Yiu Lam, Trotman, Judith, Forsyth, Cecily J., Taper, John, Ross, David M., Beresford, Jennifer, Tam, Constantine, Mills, Anthony K., Grigg, Andrew P., Hughes, Timothy P.
Publicado no Blood (2015)